Open-Label, One Arm Pilot Investigation of Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas.

Trial Profile

Open-Label, One Arm Pilot Investigation of Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2012

At a glance

  • Drugs Lenalidomide (Primary)
  • Indications Peripheral T-cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 18 Dec 2009 Actual patient number (1) added as reported by ClinicalTrials.gov.
    • 09 Oct 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top